eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
10/2002
vol. 6
 
Share:
Share:
more
 
 
abstract:

The role of neoadjuvant hormonotherapy in patients with locally advanced breast cancer - is that a chance for agents of new generation?

Marzena Wełnicka-Jaśkiewicz, Wojciech Rogowski

Współcz Onkol (2002), vol. 6, 10, 676-685
Online publish date: 2003/03/26
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The management of locally advanced breast cancer (LABC) has changed considerably during this century. Based on the work of Halsted, radical mastectomy was established as the principal standard treatment for breast cancer at the turn of the 20th century. Subsequent reports have consistently demonstrated poor results of radical mastectomy in LABC patients. In consequence, radiation therapy used as a sole modality or as an adjunct to surgery assumed a more prominent role in the management of these patients. More recently, a systemic therapy as an adjunct to locoregional modalities became the standard of care in the majority of LABC patients. Currently most patients with LABC are treated with primary chemotherapy or, especially in elderly patients, with hormonal agents. Tamoxifen has been the treatment of choice in that group of patients until selective aromatase inhibitors were introduced. These compounds were found to be more active than tamoxifen in metastaic breast cancer and in LABC. Most recently, a remarkable activity of novel class of agents, selective estrogen receptor modulators (SERM) has been demonstrated. The aim of this paper is to review the role of primary hormonotherapy in LABC patients with the potential, focus on recently introduced hormonal agents.
keywords:

breast cancer, hormonotherapy

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe